Noile-Immune Biotech Inc (4893) Stock Price & News

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1.00M	-	-	-
Cost of goods sold	-	52.00M	-	-
Cost of revenue	-	52.00M	-	-
Research and development expenses	93.00M	72.00M	86.00M	107.00M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	104.00M	11.00M	116.00M	110.00M
Operating expense	197.00M	137.00M	202.00M	217.00M
Total operating expenses	197.00M	189.00M	202.00M	217.00M
Operating income	-196.00M	-189.00M	-202.00M	-217.00M
Other non operating income	-1.00M	1.00M	45.00M	-1.00M
EBT including unusual items	-193.00M	-188.00M	-153.00M	-218.00M
EBT excluding unusual items	-193.00M	-188.00M	-153.00M	-218.00M
Income tax expense	1.00M	-	-	1.00M
Effective tax rate	-0.52%	-	-	-0.46%
Other operating expenses	-	54.00M	-	-
Net income	-194.00M	-188.00M	-153.00M	-219.00M
Net profit margin	-19,400.00%	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	4.00M	-	4.00M	-
Interest expense	-	-	-	-
Net interest expenses	4.00M	-	4.00M	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance